SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-17-006923
Filing Date
2017-04-21
Accepted
2017-04-21 08:35:56
Documents
3
Filing Date Changed
2017-04-21
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20170414_defa14a.htm DEFA14A 23624
2 notice2.jpg GRAPHIC 287520
3 notice1.jpg GRAPHIC 244279
  Complete submission text file 0001437749-17-006923.txt   757222
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 17774268
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1